SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:9c7e0f0f-7442-411e-a0c2-32bad59098b3"
 

Search: onr:"swepub:oai:lup.lub.lu.se:9c7e0f0f-7442-411e-a0c2-32bad59098b3" > SARS-CoV-2 Infectio...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood

Lugar, Marija (author)
Dresden University of Technology
Eugster, Anne (author)
Dresden University of Technology
Achenbach, Peter (author)
Helmholtz Zentrum München,Technical University of Munich
show more...
von dem Berge, Thekla (author)
Children's Hospital Auf der Bult
Berner, Reinhard (author)
University Clinic Carl Gustav Carus at the TU Dresden
Besser, Rachel E J (author)
Oxford University Hospital
Casteels, Kristina (author)
Catholic University of Leuven,University Hospitals Leuven
Elding Larsson, Helena (author)
Lund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Pediatrisk endokrinologi,Forskargrupper vid Lunds universitet,Department of Clinical Sciences, Malmö,Faculty of Medicine,Paediatric Endocrinology,Lund University Research Groups,Skåne University Hospital
Gemulla, Gita (author)
University Clinic Carl Gustav Carus at the TU Dresden,Dresden University of Technology
Kordonouri, Olga (author)
Children's Hospital Auf der Bult
Lindner, Annett (author)
Dresden University of Technology
Lundgren, Markus (author)
Lund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Pediatrisk endokrinologi,Forskargrupper vid Lunds universitet,Department of Clinical Sciences, Malmö,Faculty of Medicine,Paediatric Endocrinology,Lund University Research Groups,Central Hospital Kristianstad
Müller, Denise (author)
Dresden University of Technology
Oltarzewski, Mariusz (author)
National Research Institute of Mother and Child
Rochtus, Anne (author)
Catholic University of Leuven,University Hospitals Leuven
Scholz, Marlon (author)
Technical University of Munich,Helmholtz Zentrum München
Szypowska, Agnieszka (author)
Medical University of Warsaw
Todd, John A (author)
University of Oxford
Ziegler, Anette-Gabriele (author)
Technical University of Munich,Helmholtz Zentrum München
Bonifacio, Ezio (author)
University Clinic Carl Gustav Carus at the TU Dresden,Helmholtz Zentrum München,Dresden University of Technology
show less...
 (creator_code:org_t)
 
2023
2023
English 10 s.
In: JAMA. - 0098-7484. ; 330:12
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • IMPORTANCE: The incidence of diabetes in childhood has increased during the COVID-19 pandemic. Elucidating whether SARS-CoV-2 infection is associated with islet autoimmunity, which precedes type 1 diabetes onset, is relevant to disease etiology and future childhood diabetes trends.OBJECTIVE: To determine whether there is a temporal relationship between SARS-CoV-2 infection and the development of islet autoimmunity in early childhood.DESIGN, SETTING, AND PARTICIPANTS: Between February 2018 and March 2021, the Primary Oral Insulin Trial, a European multicenter study, enrolled 1050 infants (517 girls) aged 4 to 7 months with a more than 10% genetically defined risk of type 1 diabetes. Children were followed up through September 2022.EXPOSURE: SARS-CoV-2 infection identified by SARS-CoV-2 antibody development in follow-up visits conducted at 2- to 6-month intervals until age 2 years from April 2018 through June 2022.MAIN OUTCOMES AND MEASURES: The development of multiple (≥2) islet autoantibodies in follow-up in consecutive samples or single islet antibodies and type 1 diabetes. Antibody incidence rates and risk of developing islet autoantibodies were analyzed.RESULTS: Consent was obtained for 885 (441 girls) children who were included in follow-up antibody measurements from age 6 months. SARS-CoV-2 antibodies developed in 170 children at a median age of 18 months (range, 6-25 months). Islet autoantibodies developed in 60 children. Six of these children tested positive for islet autoantibodies at the same time as they tested positive for SARS-CoV-2 antibodies and 6 at the visit after having tested positive for SARS-CoV-2 antibodies. The sex-, age-, and country-adjusted hazard ratio for developing islet autoantibodies when the children tested positive for SARS-CoV-2 antibodies was 3.5 (95% CI, 1.6-7.7; P = .002). The incidence rate of islet autoantibodies was 3.5 (95% CI, 2.2-5.1) per 100 person-years in children without SARS-CoV-2 antibodies and 7.8 (95% CI, 5.3-19.0) per 100 person-years in children with SARS-CoV-2 antibodies (P = .02). Islet autoantibody risk in children with SARS-CoV-2 antibodies was associated with younger age (<18 months) of SARS-CoV-2 antibody development (HR, 5.3; 95% CI, 1.5-18.3; P = .009).CONCLUSION AND RELEVANCE: In young children with high genetic risk of type 1 diabetes, SARS-CoV-2 infection was temporally associated with the development of islet autoantibodies.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

  • JAMA (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view